CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- 4 Planned sale EVP, Head of North America sold 6,166 shares at $28.05 ($172,958)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale EVP, Head of North America sold 12,941 shares at an average $24.24 ($313,713)
- 4 Planned sale Chief Human Resources Officer sold 930 shares at $17.64 ($16,405)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Financial Officer acquired 2,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Accounting Officer sold 912 shares at $17.50 ($15,960)
- 4 Other acquisition Director acquired 5,771 shares (other)
- 4 Open-market sale EVP, Head of International sold 1,177 shares at $27.03 ($31,814)
- 4 Open-market sale Chief Technical Officer sold 554 shares at $26.87 ($14,886)
- 4 Open-market sale EVP, Head of North America sold 635 shares at $26.87 ($17,062)
- 4 Open-market sale Chief Financial Officer sold 702 shares at $26.87 ($18,863)
- 4 Option exercise EVP, Head of International acquired 2,031 shares (option exercise)
Page 10 of 22 · 430 filings